Long-term safety and efficacy of add-on cannabidiol for treatment of seizures associated with tuberous sclerosis complex in an open-label extension

被引：0

作者：

Kwan, Patrick ^{[1
,2
]}

Thiele, Elizabeth A. ^{[3
]}

Bebin, E. Martina ^{[4
]}

Filloux, Francis ^{[5
]}

Jansen, Floor E. ^{[6
]}

Loftus, Rachael ^{[7
]}

Sahebkar, Farhad ^{[8
]}

Sparagana, Steven ^{[9
,10
]}

Wheless, James ^{[11
,12
]}

机构：

[1] Monash Univ, Melbourne, Vic, Australia

[2] Univ Melbourne, Melbourne, Vic, Australia

[3] Massachusetts Gen Hosp, Boston, MA 02114 USA

[4] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA

[5] Univ Utah, Sch Med, Salt Lake City, UT USA

[6] Univ Med Ctr, Brain Ctr, Utrecht, Netherlands

[7] GW Res Ltd, Cambridge, England

[8] Greenwich Biosci Inc, Carlsbad, CA USA

[9] Scottish Rite Children, Dallas, TX USA

[10] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[11] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA

[12] Le Bonheur Childrens Hosp, Memphis, TN USA

来源：

EPILEPSIA | 2021年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

135

引用

页码：145 / 146

页数：2

共 50 条

[21] COST-EFFECTIVENESS OF CANNABIDIOL ADD-ON THERAPY VERSUS PLACEBO FOR THE TREATMENT OF SEIZURES IN TUBEROUS SCLEROSIS COMPLEX
Bowditch, S.
Burke, C.
Crossan, C.
Hemstock, M.
Tyas, E.
Lee, D.
VALUE IN HEALTH, 2022, 25 (12) : S56 - S56
[22] Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
Devinsky, Orrin
Nabbout, Rima
Miller, Ian
Laux, Linda
Zolnowska, Marta
Wright, Stephen
Roberts, Claire
EPILEPSIA, 2019, 60 (02) : 294 - 302
[23] Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet Syndrome: Results of the Open-Label Extension Trial (GWPCARE5)
Devinsky, O.
Nabbout, R.
Miller, I.
Laux, L.
Zolnowska, M.
Wright, S.
Roberts, C.
EPILEPSIA, 2018, 59 : S73 - S73
[24] Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
Klein, Pavel
Aboumatar, Sami
Brandt, Christian
Dong, Fang
Krauss, Gregory L.
Mizne, Sarah
Sanchez-Alvarez, Juan Carlos
Steinhoff, Bernhard J.
Villanueva, Vicente
NEUROLOGY, 2022, 99 (10) : E989 - E998
[25] Long-term safety of pregabalin add-on treatment in patients with partial-onset seizures: pooled analysis of six open-label clinical studies
Leon, T.
Uthman, B.
Bazil, C.
Schulze-Bonhage, A.
Whalen, E.
Emir, B.
Benabou, R.
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 89 - 90
[26] Long-term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic-clonic seizures: An open-label extension trial
Vossler, David G.
Farkas, Mark Kristof
Poverennova, Irina
Watanabe, Masako
Conrath, Peter
Dimova, Svetlana
McClung, Carrie
Roebling, Robert
Williams, Paulette
O'Brien, Terence J.
EPILEPSIA, 2024, 65 (12) : 3488 - 3500
[27] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
Grossman, J
Smith, LJ
Wilson, AM
Thyrum, PT
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
[28] Open-label long-term treatment of add-on triheptanoin in adults with drug-resistant epilepsy
Borges, Karin
Kaul, Neha
Germaine, Jack
Carrasco-Pozo, Catalina
Kwan, Patrick
O'Brien, Terence J.
EPILEPSIA OPEN, 2020, 5 (02) : 230 - 239
[29] Long-term seizure freedom in patients with partial seizures treated with add-on pregabalin: An analysis of four long-term, open-label trials
Spiegel, K
Baulac, M
Lee, CM
Barrett, J
NEUROLOGY, 2004, 62 (07) : A314 - A315
[30] Long-term seizure freedom in patients with partial seizures treated with add-on pregabalin: An analysis of four, long-term, open-label trials
Uthman, B
Lee, C
Spiegel, K
EPILEPSIA, 2004, 45 : 294 - 294

← 1 2 3 4 5 →